Nirman Agri

When is the next results date for Nirman Agri?

No Upcoming Board Meetings

Has Nirman Agri declared dividend?

Yes, Nirman Agri Genetics Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of September 25, 2024. While the company shows a strong total return of 108.86% over the last 2 years, recent performance has been mixed, with a -42.79% return in the last 6 months.

Nirman Agri Genetics Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2 per share<BR>- Ex-date: 25 Sep 24<BR><BR>Dividend Yield: 0.84%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -42.79%, the dividend return was 0%, resulting in a total return of -42.79%.<BR><BR>Over the past year, the price return was 13.24%, the dividend return was 0.97%, leading to a total return of 14.21%.<BR><BR>In the 2-year period, the price return was 107.25%, the dividend return was 1.61%, culminating in a total return of 108.86%.<BR><BR>For the 3-year period, both the price return and dividend return were 0%, resulting in a total return of 0.0%.<BR><BR>In the 4-year period, there were no price or dividend returns, leading to a total return of 0.0%.<BR><BR>Over the last 5 years, the price return and dividend return remained at 0%, resulting in a total return of 0.0%.<BR><BR>Overall, while Nirman Agri Genetics Ltd has declared a dividend, the total returns over different periods show significant variability, with a notably high return in the 2-year period but negative returns in the recent 6-month period. This indicates a mixed performance in terms of dividends and overall returns.

Who are the peers of the Nirman Agri?

Nirman Agri's peers include L T Foods, KRBL, Kaveri Seed Co., and others, with varying management and growth risks. Naturite Agro has the highest 1-year return at 313.93%, while Nirman Agri's return is 0.00%.

Peers: The peers of Nirman Agri are L T Foods, KRBL, Kaveri Seed Co., Guj. Ambuja Exp, GRM Overseas, Naturite Agro, JK Agri Genetics, Kohinoor Foods, Himalaya Food, Shreeoswal Seeds.<BR><BR>Quality Snapshot: Excellent management risk is observed at Kaveri Seed Co., while Good management risk is found at L T Foods and the rest. Average management risk is present at KRBL, Guj. Ambuja Exp, and GRM Overseas, while Below Average management risk is noted at Naturite Agro, JK Agri Genetics, Himalaya Food, and Shreeoswal Seeds. Kohinoor Foods does not qualify for management risk assessment. For growth, Nirman Agri stands out with Excellent growth, while Good growth is seen at L T Foods, and Below Average growth is found at KRBL, Kaveri Seed Co., Guj. Ambuja Exp, GRM Overseas, Naturite Agro, JK Agri Genetics, Himalaya Food, and Shreeoswal Seeds. Kohinoor Foods does not qualify for growth assessment. In terms of capital structure, Excellent capital structure is noted at Kaveri Seed Co., KRBL, Guj. Ambuja Exp, and the rest have Below Average or do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Naturite Agro at 313.93%, while the peer with the lowest is Himalaya Food at -36.25%. Nirman Agri's 1-year return is 0.00%, which is significantly lower than both extremes. Additionally, the six-month return is negative for Guj. Ambuja Exp, JK Agri Genetics, Himalaya Food, and Shreeoswal Seeds.

What is the technical trend for Nirman Agri?

As of June 4, 2025, Nirman Agri's trend has shifted to mildly bearish, driven by bearish daily moving averages and Bollinger Bands, despite a mildly bullish MACD on the weekly chart, with the stock down 11.36% over the past week and 11.31% over the past month.

As of 4 June 2025, the technical trend for Nirman Agri has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a bearish trend and the Bollinger Bands showing bearish signals on both weekly and monthly time frames. The MACD on a weekly basis is mildly bullish, but this is countered by the overall bearish indicators from the moving averages and Bollinger Bands. The Dow Theory reflects a mildly bullish stance on the weekly chart, but is bearish on the monthly, further contributing to the mixed signals. Overall, the strength of the bearish trend is reinforced by the recent price action, with the stock down 11.36% over the past week and 11.31% over the past month, significantly underperforming the Sensex.

What does Nirman Agri do?

Nirman Agri Genetics Ltd is a Micro Cap company in the Other Agricultural Products industry, incorporated in 2020 and transitioned to a Public Limited status in 2022. As of March 2025, it reported net sales of 630 Cr and a net profit of 69 Cr, with a market cap of INR 138 Cr.

Overview:<BR>Nirman Agri Genetics Ltd operates in the Other Agricultural Products industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Nirman Agri Genetics Limited was incorporated as Nirman Agri Genetics Private Limited in 2020. The company transitioned to a Public Limited status on December 5, 2022, with a fresh certificate of incorporation issued on January 3, 2023. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 630 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 69 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 138 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 5.00 <BR>Industry P/E: 18 <BR>Dividend Yield: 1.12% <BR>Debt-Equity: -0.23 <BR>Return on Equity: 23.00% <BR>Price to Book: 1.30 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the Nirman Agri?

The top shareholders of Nirman Agri include promoter Pranav Kailas Bagal with 57.95%, individual investors at 38.47%, and public shareholder Niraj Umesh Joshi with 2.19%. There are no pledged promoter holdings or mutual fund investments in the company.

The top shareholders of Nirman Agri are primarily its promoters, with Pranav Kailas Bagal holding the largest share at 57.95%. Individual investors collectively own 38.47% of the company, while the highest public shareholder is Niraj Umesh Joshi, who holds 2.19%. Additionally, there are three foreign institutional investors (FIIs) that hold a combined 0.04% of the shares. Notably, there are no pledged promoter holdings and no mutual fund schemes currently invested in the company.

How big is Nirman Agri?

As of 24th July, Nirman Agri Genetics Ltd has a market capitalization of 141.00 Cr, with recent net sales of 236.51 Cr and a net profit of 25.11 Cr. The balance sheet for March 2024 shows shareholder's funds of 37.34 Cr and total assets of 44.25 Cr.

As of 24th July, Nirman Agri Genetics Ltd has a market capitalization of 141.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Nirman Agri reported Net Sales of 236.51 Cr and a Net Profit of 25.11 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 37.34 Cr and Total Assets of 44.25 Cr.

Is Nirman Agri overvalued or undervalued?

As of August 28, 2025, Nirman Agri is considered very attractive due to its undervalued status with a PE ratio of 4.53, an EV to EBITDA of 3.36, and a PEG ratio of 0.06, indicating significant growth potential compared to peers like Kaveri Seed Co. and Nath Bio-Genes, despite a year-to-date stock performance lagging at -63.69% versus the Sensex's 3.62%.

As of 28 August 2025, the valuation grade for Nirman Agri has moved from attractive to very attractive. The company is currently undervalued, with a PE ratio of 4.53, an EV to EBITDA of 3.36, and a PEG ratio of 0.06, indicating significant potential for growth relative to its price. <BR><BR>In comparison to its peers, Nirman Agri's valuation metrics stand out; for instance, Kaveri Seed Co. has a PE ratio of 18.70, while Nath Bio-Genes has a PE of 7.78. This suggests that Nirman Agri is trading at a substantial discount compared to these companies. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -63.69% compared to the Sensex's 3.62%, the underlying financial ratios indicate that the stock is fundamentally undervalued and presents a compelling investment opportunity.

How has been the historical performance of Nirman Agri?

Nirman Agri has shown significant growth from March 2022 to March 2025, with net sales increasing from 13.49 crore to 236.52 crore and profit after tax rising from 2.56 crore to 25.29 crore. However, the company faces cash flow challenges, reporting a negative cash outflow of 31 crore in March 2025.

Answer:<BR>The historical performance of Nirman Agri shows significant growth over the past four fiscal years, particularly from March 2022 to March 2025.<BR><BR>Breakdown:<BR>Nirman Agri's net sales have increased dramatically from 13.49 crore in March 2022 to 236.52 crore in March 2025, reflecting a strong upward trend in total operating income, which rose from 13.49 crore to 236.52 crore in the same period. The raw material cost also surged, reaching 205.17 crore by March 2025, up from just 9.43 crore in March 2022. Operating profit, excluding other income, improved from 3.42 crore in March 2022 to 26.55 crore in March 2025, while profit before tax increased from 3.42 crore to 26.07 crore over the same timeframe. Profit after tax followed suit, growing from 2.56 crore in March 2022 to 25.29 crore in March 2025. The company's earnings per share (EPS) rose significantly from 9.01 in March 2022 to 31.57 in March 2025. On the balance sheet, total assets expanded from 5.96 crore in March 2022 to 113.19 crore in March 2025, with total liabilities increasing from 5.96 crore to 113.19 crore as well. Cash flow from operating activities showed a negative trend, with a cash outflow of 31 crore in March 2025, despite a net cash inflow of 24 crore for the same period. Overall, Nirman Agri has demonstrated substantial growth in revenue and profitability, although it faces challenges in cash flow management.

Should I buy, sell or hold Nirman Agri Genetics Ltd?

Which are the latest news on Nirman Agri?

Why is Nirman Agri Genetics Ltd falling/rising?

As of 07-Apr, Nirman Agri Genetics Ltd's stock price is rising to 46.90, reflecting a 4.92% increase due to positive recent financial performance. However, the stock has a concerning long-term outlook with a year-to-date decline of 24.29% and an 80.69% drop over the past year.

As of 07-Apr, Nirman Agri Genetics Ltd's stock price is rising, currently at 46.90, reflecting a change of 2.2 (4.92%) upwards. This increase can be attributed to the company's recent positive financial performance, including a growth in net sales of 3.16% and a significant increase in net sales over the last six months, which reached Rs 124.07 crore, growing at 215.30%. Additionally, the company has reported positive results for the last four consecutive quarters, which may have bolstered investor confidence.<BR><BR>Despite this positive short-term performance, it is important to note that the stock has experienced a substantial decline over the longer term, with a year-to-date decrease of 24.29% and an alarming drop of 80.69% over the past year. Furthermore, the stock's performance has been below par compared to the benchmark Sensex, which has risen by 4.34% over the same period. The stock is also facing challenges such as falling investor participation, with a delivery volume that has decreased by 57.75% against the five-day average.<BR><BR>In summary, while the stock is currently rising due to recent positive financial results, its long-term outlook remains weak, and it has underperformed significantly over the past year.

Why is Nirman Agri Genetics Ltd falling/rising?

As of 08-Apr, Nirman Agri Genetics Ltd's stock price is rising to 49.20, driven by a 3.16% growth in net sales and strong quarterly results, but concerns about declining investor participation and long-term performance risks remain.

As of 08-Apr, Nirman Agri Genetics Ltd's stock price is rising, currently at 49.20, reflecting a change of 2.3, or 4.9%. This increase can be attributed to several positive factors. The company reported a growth in net sales of 3.16% and has declared very positive results for the last four consecutive quarters. Notably, net sales over the latest six months reached Rs 124.07 crore, demonstrating a significant growth of 215.30%. Additionally, the profit after tax (PAT) for the same period was Rs 13.65 crore, which has increased by 110.65%. <BR><BR>Moreover, today's performance indicates that the stock has outperformed its sector by 0.52%. The current price is also higher than the 5-day and 20-day moving averages, suggesting a short-term upward trend. However, it is important to note that there are concerns regarding falling investor participation, as the delivery volume has decreased significantly by 77.2% compared to the 5-day average. <BR><BR>Despite the positive short-term performance, the stock has a weak long-term fundamental strength due to the lack of declared results in the past six months and a substantial decline of 80.71% over the last year. This mixed outlook indicates that while the stock is currently rising, there are underlying risks that could affect its future performance.

Why is Nirman Agri Genetics Ltd falling/rising?

As of 09-Apr, Nirman Agri Genetics Ltd's stock price has risen to 51.65, driven by a 3.16% growth in net sales and positive quarterly results. However, it has a weak long-term outlook with a significant decline of -79.90% over the past year, indicating risks despite recent gains.

As of 09-Apr, Nirman Agri Genetics Ltd is experiencing a rise in its stock price, currently at 51.65, reflecting an increase of 2.45 (4.98%). This upward movement can be attributed to several factors. Notably, the company reported a growth in net sales of 3.16% and has declared positive results for the last four consecutive quarters. In the latest six months, net sales reached Rs 124.07 crore, marking a significant growth of 215.30%, while profit after tax (PAT) also saw a substantial increase of 110.65%, amounting to Rs 13.65 crore. Additionally, the stock has outperformed its sector by 4.41% today.<BR><BR>However, it is important to note that despite the recent positive performance, the stock has a weak long-term fundamental strength due to a lack of declared results in the last six months. Over the past year, the stock has generated a return of -79.90%, indicating a significant decline, even as profits have risen. The stock is considered risky compared to its average historical valuations, and it has underperformed against broader indices like the BSE500 over the last three years.<BR><BR>In summary, while Nirman Agri Genetics Ltd is currently rising due to recent positive financial results and sector outperformance, it faces challenges from its long-term performance and lack of recent disclosures.